Brii Bio Appoints Coy Stout as Senior Vice President and Head of U.S. Market Access and Patient Advocacy
|[27-September-2021]|
Strategic senior hire strengthens Brii Bio’ leadership team and positions the Company for U.S. market access and commercialization
DURHAM, N.C. and BEIJING, Sept. 27, 2021 /PRNewswire/ — Brii Biosciences Limited (“Brii Bio” or the “Company”, stock code: 2137.HK) a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, today announced the appointment of Coy Stout as Senior Vice President and Head of U.S. Market Access and Patient Advocacy. Mr …
Read the source article at biospace.com
2021-09-28 04:00:00
